The importance of the PD-1/PD-L1 pathway in the tumor microenvironment was also demonstrated in a study of 193 patients with large cell neuroendocrine carcinoma or SCLC examined for PD-L1 expression on tumor cells and tumor-infiltrating immune cells. Here, CD274 is linked to small cell lung carcinoma.